Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PM vs MRNA✓SelectedUSD · MRNAPM vs MRNA performance historyLatest closeAs of-1.26%11/20
Stock and ETF performance explorer

PM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+226.1%
MRNA return
+786.4%
Excess return
-560.2%
Maximum drawdown
-31.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.3%-2.2%+0.9%-1.2%
7D-7.5%-12.7%+5.2%-7.4%
30D-6.8%-20.7%+13.9%-6.7%
3M-3.1%+46.3%-49.3%-3.3%
6M-0.8%+305.2%-306.0%-1.8%
YTD+17.8%+561.2%-543.5%+16.1%
1Y+22.5%+772.1%-749.6%+20.6%
3Y+125.4%+147.0%-21.6%+124.3%
5Y+156.3%-26.1%+182.4%+155.8%
All+226.1%+786.4%-560.2%+206.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling